257 related articles for article (PubMed ID: 9804346)
1. Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars.
Krötzsch-Gómez FE; Furuzawa-Carballeda J; Reyes-Márquez R; Quiróz-Hernández E; Díaz de León L
J Invest Dermatol; 1998 Nov; 111(5):828-34. PubMed ID: 9804346
[TBL] [Abstract][Full Text] [Related]
2. Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.
Kuroda K; Okamoto O; Shinkai H
J Invest Dermatol; 1999 May; 112(5):706-10. PubMed ID: 10233760
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1beta, TNF-alpha, TGF-beta1, ELAM-1 and VCAM-1 expression in scleroderma skin lesions.
Furuzawa-Carballeda J; Krötzsch E; Barile-Fabris L; Alcalá M; Espinosa-Morales R
Clin Exp Dermatol; 2005 Jan; 30(1):83-6. PubMed ID: 15663512
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars.
Niessen FB; Andriessen MP; Schalkwijk J; Visser L; Timens W
J Pathol; 2001 Jun; 194(2):207-16. PubMed ID: 11400150
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts.
Garner WL; Karmiol S; Rodriguez JL; Smith DJ; Phan SH
J Invest Dermatol; 1993 Dec; 101(6):875-9. PubMed ID: 8245516
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of fractional CO2 laser on histopathological picture and TGF-β1 expression in hypertrophic scar.
Makboul M; Makboul R; Abdelhafez AH; Hassan SS; Youssif SM
J Cosmet Dermatol; 2014 Sep; 13(3):169-79. PubMed ID: 25196683
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory cytokine TSG-6 inhibits hypertrophic scar formation in a rabbit ear model.
Wang H; Chen Z; Li XJ; Ma L; Tang YL
Eur J Pharmacol; 2015 Mar; 751():42-9. PubMed ID: 25661977
[TBL] [Abstract][Full Text] [Related]
8. [A study on the expressions and the correlation of TGF-beta and alpha-SMA in scars].
Tian Y; Tang S; Luo S
Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):75-7. PubMed ID: 11593622
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation.
Dasu MR; Hawkins HK; Barrow RE; Xue H; Herndon DN
J Pathol; 2004 Apr; 202(4):476-85. PubMed ID: 15095275
[TBL] [Abstract][Full Text] [Related]
11. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
12. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
[TBL] [Abstract][Full Text] [Related]
13. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring.
Wang J; Jiao H; Stewart TL; Shankowsky HA; Scott PG; Tredget EE
Wound Repair Regen; 2007; 15(4):530-9. PubMed ID: 17650097
[TBL] [Abstract][Full Text] [Related]
14. Post-burn hypertrophic scars are characterized by high levels of IL-1β mRNA and protein and TNF-α type I receptors.
Salgado RM; Alcántara L; Mendoza-Rodríguez CA; Cerbón M; Hidalgo-González C; Mercadillo P; Moreno LM; Alvarez-Jiménez R; Krötzsch E
Burns; 2012 Aug; 38(5):668-76. PubMed ID: 22226222
[TBL] [Abstract][Full Text] [Related]
15. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
16. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
17. [The effects of PDGF-AB on pro alpha 1 (III). mRNA expression of fibroblasts].
Dong M; Chen B; Xu M
Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):78-80. PubMed ID: 11593623
[TBL] [Abstract][Full Text] [Related]
18. [Study on the biological function of vascular endothelial cells in the hypertrophic scar].
Wang XQ; Lu SL; Mao ZG; Liu YK
Zhonghua Shao Shang Za Zhi; 2007 Jun; 23(3):219-21. PubMed ID: 18019066
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
[TBL] [Abstract][Full Text] [Related]
20. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
